Objective This study was conducted to determine if reduction of early
postburn endotoxemia influences the cytokine cascade, clinical manifes
tations of sepsis, and mortality rate. Summary Background Data Translo
cational endotoxemia has been demonstrated postburn in animals and hum
ans. Endotoxin is known to induce the cytokine cascade, which leads to
the clinical manifestations of sepsis. Whether reduction of postburn
endotoxemia could influence the induction of cytokines has not been de
monstrated. Methods In a prospective, randomized study, 76 burn patien
ts were given polymyxin intravenously or served as control subjects. P
olymyxin B was given intravenously for 1 week postburn in doses design
ed to neutralize circulating endotoxemia. Results In the polymyxin gro
up, there was a statistically significant reduction in the plasma endo
toxin concentration. There was, however, no reduction in the sepsis sc
ore or the interleukin-6 levels, and no differences in mortality rates
were seen between the two groups. Conclusions Early postburn transloc
ational endotoxemia can be treated with anti-endotoxin agents such as
polymyxin B. This, however, does not influence the cytokine cascade or
the mortality rate. The systemic inflammatory response syndrome is ca
used by cytokine induction from the injury and is unaffected by a redu
ction in the plasma endotoxin concentration.